Vanguard Investments Australia
GILD icon

Vanguard Investments Australia’s Gilead Sciences GILD Stock Holding History

Vanguard Investments Australia’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.2M Buy
634,457
+15,500
+3% +$2.04M 0.2% 85
2026
Q1 		$86.3M Buy
+618,957
New +$86.7M 0.25% 70

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Investments Australia's GILD Position: Q2 2026 in Review

Vanguard Investments Australia increased its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, buying an estimated $2.04M and bringing the position to 634,457 shares worth $80.2M. The position accounts for 0.2% of the portfolio, ranked #85.

Vanguard Investments Australia first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $86.3M in Q1 2026. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vanguard Investments Australia held 634,457 shares of Gilead Sciences worth $80.2M as of Q2 2026.
  • Vanguard Investments Australia bought 15,500 Gilead Sciences shares in Q2 2026, an estimated $2.04M.
  • Gilead Sciences made up 0.2% of Vanguard Investments Australia's portfolio in Q2 2026, its #85 holding.
  • Vanguard Investments Australia first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Gilead Sciences position peaked at $86.3M in Q1 2026.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.